Chapter 4 Histone Demethylases and Cancer

Advances in Cancer Research

Volumn 102, Issue , 2009, Pages 103-169

  Kampranis, Sotirios C ^a   Tsichlis, Philip N ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMINE OXIDASE (FLAVIN CONTAINING); ANTINEOPLASTIC AGENT; ARGININE; AZACITIDINE; DNA METHYLTRANSFERASE INHIBITOR; ENZYME; HISTONE DEACETYLASE INHIBITOR; HISTONE DEMETHYLASE; HISTONE DEMETHYLASE INHIBITOR; POLYAMINE DERIVATIVE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; HISTONE; N DEMETHYLASE;

CANCER THERAPY; CARCINOGENESIS; CARCINOMA CELL; CATALYSIS; CELL GROWTH; CELL PROLIFERATION; CHROMATIN STRUCTURE; COLON CARCINOMA; DNA MODIFICATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME STRUCTURE; EPIGENETICS; GENE AMPLIFICATION; GENE CONTROL; GENE MUTATION; GENE OVEREXPRESSION; HELA CELL; HUMAN; METHYLATION; MUTAGENESIS; NEOPLASM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROVIRUS; RETROVIRUS; REVIEW; TUMOR SUPPRESSOR GENE; ANIMAL; DNA METHYLATION; ENZYMOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; NEOPLASMS; OXIDOREDUCTASES, N-DEMETHYLATING;

EID: 67649781191     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(09)02004-1     Document Type: Review

References (292)

1. Abidi F.E., Miano M.G., Murray J.C., and Schwartz C.E. A novel mutation in the PHF8 gene is associated with X-linked mental retardation with cleft lip/cleft palate. Clin. Genet. 72 (2007) 19-22
2. Abidi F.E., Holloway L., Moore C.A., Weaver D.D., Simensen R.J., Stevenson R.E., Rogers R.C., and Schwartz C.E. Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia. J. Med. Genet. 45 (2008) 787-793
3. Agger K., Cloos P.A., Christensen J., Pasini D., Rose S., Rappsilber J., Issaeva I., Canaani E., Salcini A.E., and Helin K. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449 (2007) 731-734
4. Akahira J., Suzuki F., Suzuki T., Miura I., Kamogawa N., Miki Y., Ito K., Yaegashi N., and Sasano H. Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: Correlation with epigenetic inactivation by aberrant DNA methylation. Pathol. Int. 57 (2007) 725-733
5. Ancelin K., Lange U.C., Hajkova P., Schneider R., Bannister A.J., Kouzarides T., and Surani M.A. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat. Cell Biol. 8 (2006) 623-630
6. Annunziato A.T., Eason M.B., and Perry C.A. Relationship between methylation and acetylation of arginine-rich histones in cycling and arrested HeLa cells. Biochemistry 34 (1995) 2916-2924
7. Ayoub N., Noma K., Isaac S., Kahan T., Grewal S.I., and Cohen A. A novel jmjC domain protein modulates heterochromatization in fission yeast. Mol. Cell. Biol. 23 (2003) 4356-4370
8. Bachmann N., Hoegel J., Haeusler J., Kuefer R., Herkommer K., Paiss T., Vogel W., and Maier C. Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer. Prostate 65 (2005) 252-259
9. Bachmann I.M., Halvorsen O.J., Collett K., Stefansson I.M., Straume O., Haukaas S.A., Salvesen H.B., Otte A.P., and Akslen L.A. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol. 24 (2006) 268-273
10. Balakrishnan A., Bleeker F.E., Lamba S., Rodolfo M., Daniotti M., Scarpa A., van Tilborg A.A., Leenstra S., Zanon C., and Bardelli A. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res. 67 (2007) 3545-3550
11. Balciunas D., and Ronne H. Evidence of domain swapping within the jumonji family of transcription factors. Trends Biochem. Sci. 25 (2000) 274-276
12. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., and Kouzarides T. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410 (2001) 120-124
13. Bannister A.J., Schneider R., and Kouzarides T. Histone methylation: Dynamic or static?. Cell 109 (2002) 801-806
14. Barrett A., Madsen B., Copier J., Lu P.J., Cooper L., Scibetta A.G., Burchell J., and Taylor-Papadimitriou J. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: A new cancer/testis antigen?. Int. J. Cancer 101 (2002) 581-588
15. Barrett A., Santangelo S., Tan K., Catchpole S., Roberts K., Spencer-Dene B., Hall D., Scibetta A., Burchell J., Verdin E., Freemont P., and Taylor-Papadimitriou J. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases. Int. J. Cancer 121 (2007) 265-275
16. Bedford M.T., and Richard S. Arginine methylation an emerging regulator of protein function. Mol. Cell 18 (2005) 263-272
17. Benevolenskaya E.V., Murray H.L., Branton P., Young R.A., and Kaelin Jr. W.G. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 18 (2005) 623-635
18. Berger S.L. The complex language of chromatin regulation during transcription. Nature 447 (2007) 407-412
19. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., Jaenisch R., Wagschal A., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 (2006) 315-326
20. Bernstein B.E., Meissner A., and Lander E.S. The mammalian epigenome. Cell 128 (2007) 669-681
21. Beyer S., Kristensen M.M., Jensen K.S., Johansen J.V., and Staller P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 283 (2008) 36542-36552
22. Bhaumik S.R., Smith E., and Shilatifard A. Covalent modifications of histones during development and disease pathogenesis. Nat. Struct. Mol. Biol. 14 (2007) 1008-1016
23. Blackburn E.H. Telomere states and cell fates. Nature 408 (2000) 53-56
24. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
25. Bolden J.E., Peart M.J., and Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5 (2006) 769-784
26. Borges M., Linnoila R.I., van de Velde H.J., Chen H., Nelkin B.D., Mabry M., Baylin S.B., and Ball D.W. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 386 (1997) 852-855
27. Borun T.W., Pearson D., and Paik W.K. Studies of histone methylation during the HeLa S-3 cell cycle. J. Biol. Chem. 247 (1972) 4288-4298
28. Bracken A.P., Pasini D., Capra M., Prosperini E., Colli E., and Helin K. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22 (2003) 5323-5335
29. Bres V., Yoh S.M., and Jones K.A. The multi-tasking P-TEFb complex. Curr. Opin. Cell Biol. 20 (2008) 334-340
30. Bryant R.J., Cross N.A., Eaton C.L., Hamdy F.C., and Cunliffe V.T. EZH2 promotes proliferation and invasiveness of prostate cancer cells. Prostate 67 (2007) 547-556
31. Bushman F., Lewinski M., Ciuffi A., Barr S., Leipzig J., Hannenhalli S., and Hoffmann C. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3 (2005) 848-858
32. Byvoet P., Shepherd G.R., Hardin J.M., and Noland B.J. The distribution and turnover of labeled methyl groups in histone fractions of cultured mammalian cells. Arch. Biochem. Biophys. 148 (1972) 558-567
33. Cao R., and Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14 (2004) 155-164
34. Cao R., Tsukada Y., and Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20 (2005) 845-854
35. Carling T., Kim K.C., Yang X.H., Gu J., Zhang X.K., and Huang S. A histone methyltransferase is required for maximal response to female sex hormones. Mol. Cell. Biol. 24 (2004) 7032-7042
36. Carrozza M.J., Li B., Florens L., Suganuma T., Swanson S.K., Lee K.K., Shia W.J., Anderson S., Yates J., Washburn M.P., and Workman J.L. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 123 (2005) 581-592
37. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., Aswad D.W., and Stallcup M.R. Regulation of transcription by a protein methyltransferase. Science 284 (1999) 2174-2177
38. Chen Y., Yang Y., Wang F., Wan K., Yamane K., Zhang Y., and Lei M. Crystal structure of human histone lysine-specific demethylase 1 (LSD1). Proc. Natl. Acad. Sci. USA 103 (2006) 13956-13961
39. Chen Z., Zang J., Whetstine J., Hong X., Davrazou F., Kutateladze T.G., Simpson M., Mao Q., Pan C.H., Dai S., Hagman J., Hansen K., et al. Structural insights into histone demethylation by JMJD2 family members. Cell 125 (2006) 691-702
40. Chen L.B., Xu J.Y., Yang Z., and Wang G.B. Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration. World J. Gastroenterol. 13 (2007) 5718-5724
41. Chen Z., Zang J., Kappler J., Hong X., Crawford F., Wang Q., Lan F., Jiang C., Whetstine J., Dai S., Hansen K., Shi Y., et al. Structural basis of the recognition of a methylated histone tail by JMJD2A. Proc. Natl. Acad. Sci. USA 104 (2007) 10818-10823
42. Cheung N., Chan L.C., Thompson A., Cleary M.L., and So C.W. Protein arginine-methyltransferase-dependent oncogenesis. Nat. Cell Biol. 9 (2007) 1208-1215
43. Cloos P.A., Christensen J., Agger K., Maiolica A., Rappsilber J., Antal T., Hansen K.H., and Helin K. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442 (2006) 307-311
44. Collado M., Blasco M.A., and Serrano M. Cellular senescence in cancer and aging. Cell 130 (2007) 223-233
45. Constantinides P.G., Jones P.A., and Gevers W. Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature 267 (1977) 364-366
46. Couture J.F., Collazo E., Brunzelle J.S., and Trievel R.C. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase. Genes Dev. 19 (2005) 1455-1465
47. Couture J.F., Collazo E., Ortiz-Tello P.A., Brunzelle J.S., and Trievel R.C. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase. Nat. Struct. Mol. Biol. 14 (2007) 689-695
48. Croonquist P.A., and Van Ness B. The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype. Oncogene 24 (2005) 6269-6280
49. Cuthbert G.L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., Schneider R., Gregory P.D., Tempst P., Bannister A.J., and Kouzarides T. Histone deimination antagonizes arginine methylation. Cell 118 (2004) 545-553
50. D'Alessio A.C., and Szyf M. Epigenetic tete-a-tete: The bilateral relationship between chromatin modifications and DNA methylation. Biochem. Cell Biol. 84 (2006) 463-476
51. Da G., Lenkart J., Zhao K., Shiekhattar R., Cairns B.R., and Marmorstein R. Structure and function of the SWIRM domain, a conserved protein module found in chromatin regulatory complexes. Proc. Natl. Acad. Sci. USA 103 (2006) 2057-2062
52. Dacwag C.S., Ohkawa Y., Pal S., Sif S., and Imbalzano A.N. The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling. Mol. Cell. Biol. 27 (2007) 384-394
53. Daser A., and Rabbitts T.H. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev. 18 (2004) 965-974
54. Defeo-Jones D., Huang P.S., Jones R.E., Haskell K.M., Vuocolo G.A., Hanobik M.G., Huber H.E., and Oliff A. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352 (1991) 251-254
55. Deng Q., and Huang S. PRDM5 is silenced in human cancers and has growth suppressive activities. Oncogene 23 (2004) 4903-4910
56. Dodge J.E., Kang Y.K., Beppu H., Lei H., and Li E. Histone H3-K9 methyltransferase ESET is essential for early development. Mol. Cell. Biol. 24 (2004) 2478-2486
57. Du Y., Jenkins N.A., and Copeland N.G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106 (2005) 3932-3939
58. Duerre J.A., and Lee C.T. In vivo methylation and turnover of rat brain histones. J. Neurochem. 23 (1974) 541-547
59. Eilbracht J., Reichenzeller M., Hergt M., Schnolzer M., Heid H., Stohr M., Franke W.W., and Schmidt-Zachmann M.S. NO66, a highly conserved dual location protein in the nucleolus and in a special type of synchronously replicating chromatin. Mol. Biol. Cell 15 (2004) 1816-1832
60. Eilbracht J., Kneissel S., Hofmann A., and Schmidt-Zachmann M.S. Protein NO52-A constitutive nucleolar component sharing high sequence homologies to protein NO66. Eur. J. Cell. Biol. 84 (2005) 279-294
61. Eissenberg J.C., and Shilatifard A. Leaving a mark: The many footprints of the elongating RNA polymerase II. Curr. Opin. Genet. Dev. 16 (2006) 184-190
62. El Messaoudi S., Fabbrizio E., Rodriguez C., Chuchana P., Fauquier L., Cheng D., Theillet C., Vandel L., Bedford M.T., and Sardet C. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc. Natl. Acad. Sci. USA 103 (2006) 13351-13356
63. Falnes P.O., Johansen R.F., and Seeberg E. AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature 419 (2002) 178-182
64. Fang J., Feng Q., Ketel C.S., Wang H., Cao R., Xia L., Erdjument-Bromage H., Tempst P., Simon J.A., and Zhang Y. Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20-specific methyltransferase. Curr. Biol. 12 (2002) 1086-1099
65. Fischle W. Talk is cheap-Cross-talk in establishment, maintenance, and readout of chromatin modifications. Genes Dev. 22 (2008) 3375-3382
66. Fischle W., Tseng B.S., Dormann H.L., Ueberheide B.M., Garcia B.A., Shabanowitz J., Hunt D.F., Funabiki H., and Allis C.D. Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438 (2005) 1116-1122
67. Fodor B.D., Kubicek S., Yonezawa M., O'Sullivan R.J., Sengupta R., Perez-Burgos L., Opravil S., Mechtler K., Schotta G., and Jenuwein T. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev. 20 (2006) 1557-1562
68. Forneris F., Binda C., Vanoni M.A., Battaglioli E., and Mattevi A. Human histone demethylase LSD1 reads the histone code. J. Biol. Chem. 280 (2005) 41360-41365
69. Forneris F., Binda C., Adamo A., Battaglioli E., and Mattevi A. Structural basis of LSD1-CoREST selectivity in histone H3 recognition. J. Biol. Chem. 282 (2007) 20070-20074
70. Foster S.L., and Medzhitov R. Gene-specific control of the TLR-induced inflammatory response. Clin. Immunol. 130 (2009) 7-15
71. Frescas D., Guardavaccaro D., Bassermann F., Koyama-Nasu R., and Pagano M. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 450 (2007) 309-313
72. Frietze S., Lupien M., Silver P.A., and Brown M. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res. 68 (2008) 301-306
73. Fukahori S., Yano H., Tsuneoka M., Tanaka Y., Yagi M., Kuwano M., Tajiri T., Taguchi T., Tsuneyoshi M., and Kojiro M. Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma. J. Pediatr. Surg. 42 (2007) 1831-1840
74. Gearhart M.D., Corcoran C.M., Wamstad J.A., and Bardwell V.J. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol. Cell. Biol. 26 (2006) 6880-6889
75. Gerber M., and Shilatifard A. Transcriptional elongation by RNA polymerase II and histone methylation. J. Biol. Chem. 278 (2003) 26303-26306
76. Glaser S., Schaft J., Lubitz S., Vintersten K., van der Hoeven F., Tufteland K.R., Aasland R., Anastassiadis K., Ang S.L., and Stewart A.F. Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development. Development 133 (2006) 1423-1432
77. Gondek L.P., Ishwaran H., Dunbar A.J., O'Keefe C.L., McDevitt M.A., Batista D., Sekeres M.A., Mufti G.J., and Maciejewski J. Array-based karyotyping and genotyping demonstrates a non random selection of allelic variants of genes in clones with 5q31 deletion mutants. ASH Annu. Meet. Abstr. 112 (2008) 2057
78. Guccione E., Bassi C., Casadio F., Martinato F., Cesaroni M., Schuchlautz H., Luscher B., and Amati B. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 449 (2007) 933-937
79. Guenther M.G., Levine S.S., Boyer L.A., Jaenisch R., and Young R.A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130 (2007) 77-88
80. Gutierrez G.M., Kong E., and Hinds P.W. Master or slave: The complex relationship of RBP2 and pRb. Cancer Cell. 7 (2005) 501-502
81. Hampsey M., and Reinberg D. Tails of intrigue: Phosphorylation of RNA polymerase II mediates histone methylation. Cell 113 (2003) 429-432
82. Hansen J.C. Conformational dynamics of the chromatin fiber in solution: Determinants, mechanisms, and functions. Annu. Rev. Biophys. Biomol. Struct. 31 (2002) 361-392
83. Harper D.P., and Aplan P.D. Chromosomal rearrangements leading to MLL gene fusions: Clinical and biological aspects. Cancer Res. 68 (2008) 10024-10027
84. Hasegawa Y., Matsubara A., Teishima J., Seki M., Mita K., Usui T., Oue N., and Yasui W. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci. 98 (2007) 32-36
85. Hasenpusch-Theil K., Chadwick B.P., Theil T., Heath S.K., Wilkinson D.G., and Frischauf A.M. PHF2, a novel PHD finger gene located on human chromosome 9q22. Mamm. Genome 10 (1999) 294-298
86. Hashimoto H., Horton J.R., Zhang X., Bostick M., Jacobsen S.E., and Cheng X. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 455 (2008) 826-829
87. Hassig C.A., Fleischer T.C., Billin A.N., Schreiber S.L., and Ayer D.E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89 (1997) 341-347
88. Hayakawa T., Ohtani Y., Hayakawa N., Shinmyozu K., Saito M., Ishikawa F., and Nakayama J. RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. Genes Cells 12 (2007) 811-826
89. He J., Kallin E.M., Tsukada Y., and Zhang Y. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat. Struct. Mol. Biol. 15 (2008) 1169-1175
90. Hediger F., and Gasser S.M. Heterochromatin protein 1: Don't judge the book by its cover!. Curr. Opin. Genet. Dev. 16 (2006) 143-150
91. Hirota T., Lipp J.J., Toh B.H., and Peters J.M. Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin. Nature 438 (2005) 1176-1180
92. Hoog C., Schalling M., Grunder-Brundell E., and Daneholt B. Analysis of a murine male germ cell-specific transcript that encodes a putative zinc finger protein. Mol. Reprod. Dev. 30 (1991) 173-181
93. Hu Z., Gomes I., Horrigan S.K., Kravarusic J., Mar B., Arbieva Z., Chyna B., Fulton N., Edassery S., Raza A., and Westbrook C.A. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31. Oncogene 20 (2001) 6946-6954
94. Huang J., Perez-Burgos L., Placek B.J., Sengupta R., Richter M., Dorsey J.A., Kubicek S., Opravil S., Jenuwein T., and Berger S.L. Repression of p53 activity by Smyd2-mediated methylation. Nature 444 (2006) 629-632
95. Huang Y., Fang J., Bedford M.T., Zhang Y., and Xu R.M. Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A. Science 312 (2006) 748-751
96. Huang J., Sengupta R., Espejo A.B., Lee M.G., Dorsey J.A., Richter M., Opravil S., Shiekhattar R., Bedford M.T., Jenuwein T., and Berger S.L. p53 is regulated by the lysine demethylase LSD1. Nature 449 (2007) 105-108
97. Huang Y., Greene E., Murray Stewart T., Goodwin A.C., Baylin S.B., Woster P.M., and Casero Jr. R.A. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc. Natl. Acad. Sci. USA 104 (2007) 8023-8028
98. Huntsman D.G., Chin S.F., Muleris M., Batley S.J., Collins V.P., Wiedemann L.M., Aparicio S., and Caldas C. MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines. Oncogene 18 (1999) 7975-7984
99. Ishizaki H., Yano H., Tsuneoka M., Ogasawara S., Akiba J., Nishida N., Kojiro S., Fukahori S., Moriya F., Matsuoka K., and Kojiro M. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol. Int. 57 (2007) 672-680
100. Ito T. Role of histone modification in chromatin dynamics. J. Biochem. 141 (2007) 609-614
101. Iwase S., Lan F., Bayliss P., de la Torre-Ubieta L., Huarte M., Qi H.H., Whetstine J.R., Bonni A., Roberts T.M., and Shi Y. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128 (2007) 1077-1088
102. Jensen L.R., Amende M., Gurok U., Moser B., Gimmel V., Tzschach A., Janecke A.R., Tariverdian G., Chelly J., Fryns J.P., Van Esch H., Kleefstra T., et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76 (2005) 227-236
103. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
104. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
105. Joshi A.A., and Struhl K. Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation. Mol. Cell 20 (2005) 971-978
106. Kahl P., Gullotti L., Heukamp L.C., Wolf S., Friedrichs N., Vorreuther R., Solleder G., Bastian P.J., Ellinger J., Metzger E., Schule R., and Buettner R. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res. 66 (2006) 11341-11347
107. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., and Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91 (1997) 649-659
108. Keogh M.C., Kurdistani S.K., Morris S.A., Ahn S.H., Podolny V., Collins S.R., Schuldiner M., Chin K., Punna T., Thompson N.J., Boone C., Emili A., et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 123 (2005) 593-605
109. Kim S., Benoiton L., and Paik W.K. Epsilon-alkyllysinase. Purification and properties of the enzyme. J. Biol. Chem. 239 (1964) 3790-3796
110. Kim K.C., Geng L., and Huang S. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res. 63 (2003) 7619-7623
111. Kim D.H., Villeneuve L.M., Morris K.V., and Rossi J.J. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat. Struct. Mol. Biol. 13 (2006) 793-797
112. Kim J., Daniel J., Espejo A., Lake A., Krishna M., Xia L., Zhang Y., and Bedford M.T. Tudor, MBT and chromo domains gauge the degree of lysine methylation. EMBO Rep. 7 (2006) 397-403
113. Kipreos E.T., and Pagano M. The F-box protein family. Genome Biol. 1 (2000) REVIEWS3002
114. Kirmizis A., Santos-Rosa H., Penkett C.J., Singer M.A., Vermeulen M., Mann M., Bahler J., Green R.D., and Kouzarides T. Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 449 (2007) 928-932
115. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., Sabel M.S., Livant D., et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA 100 (2003) 11606-11611
116. Klose R.J., Kallin E.M., and Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7 (2006) 715-727
117. Klose R.J., Yamane K., Bae Y., Zhang D., Erdjument-Bromage H., Tempst P., Wong J., and Zhang Y. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442 (2006) 312-316
118. Klose R.J., Yan Q., Tothova Z., Yamane K., Erdjument-Bromage H., Tempst P., Gilliland D.G., Zhang Y., and Kaelin Jr. W.G. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128 (2007) 889-900
119. Koivisto A.M., Ala-Mello S., Lemmela S., Komu H.A., Rautio J., and Jarvela I. Screening of mutations in the PHF8 gene and identification of a novel mutation in a Finnish family with XLMR and cleft lip/cleft palate. Clin. Genet. 72 (2007) 145-149
120. Kondo Y., Shen L., Ahmed S., Boumber Y., Sekido Y., Haddad B.R., and Issa J.P. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS ONE 3 (2008) e2037
121. Kornberg R.D., and Thomas J.O. Chromatin structure; oligomers of the histones. Science 184 (1974) 865-868
122. Kortschak R.D., Tucker P.W., and Saint R. ARID proteins come in from the desert. Trends Biochem. Sci. 25 (2000) 294-299
123. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
124. Koyama-Nasu R., David G., and Tanese N. The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun. Nat. Cell Biol. 9 (2007) 1074-1080
125. Krimpenfort P., Ijpenberg A., Song J.Y., van der Valk M., Nawijn M., Zevenhoven J., and Berns A. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448 (2007) 943-946
126. Krivtsov A.V., Feng Z., Lemieux M.E., Faber J., Vempati S., Sinha A.U., Xia X., Jesneck J., Bracken A.P., Silverman L.B., Kutok J.L., Kung A.L., et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell. 14 (2008) 355-368
127. Kubicek S., and Jenuwein T. A crack in histone lysine methylation. Cell 119 (2004) 903-906
128. Kurash J.K., Lei H., Shen Q., Marston W.L., Granda B.W., Fan H., Wall D., Li E., and Gaudet F. Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol. Cell 29 (2008) 392-400
129. Kuratomi K., Yano H., Tsuneoka M., Sakamoto K., Kusukawa J., and Kojiro M. Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma. Kurume Med. J. 53 (2006) 71-78
130. Kuzmichev A., Margueron R., Vaquero A., Preissner T.S., Scher M., Kirmizis A., Ouyang X., Brockdorff N., Abate-Shen C., Farnham P., and Reinberg D. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc. Natl. Acad. Sci. USA 102 (2005) 1859-1864
131. La Starza R., Gorello P., Rosati R., Riezzo A., Veronese A., Ferrazzi E., Martelli M.F., Negrini M., and Mecucci C. Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts. Genes Chromosomes Cancer 41 (2004) 395-399
132. Lachner M., O'Carroll D., Rea S., Mechtler K., and Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410 (2001) 116-120
133. Lagarou A., Mohd-Sarip A., Moshkin Y.M., Chalkley G.E., Bezstarosti K., Demmers J.A., and Verrijzer C.P. dKDM2 couples histone H2A ubiquitylation to histone H3 demethylation during Polycomb group silencing. Genes Dev. 22 (2008) 2799-2810
134. Lakshmikuttyamma A., Pastural E., Takahashi N., Sawada K., Sheridan D.P., DeCoteau J.F., and Geyer C.R. Bcr-Abl induces autocrine IGF-1 signaling. Oncogene 27 (2008) 3831-3844
135. Lal G., Padmanabha L., Smith B.J., Nicholson R.M., Howe J.R., O'Dorisio M.S., and Domann Jr. F.E. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 107 (2006) 2752-2759
136. Lan F., Bayliss P.E., Rinn J.L., Whetstine J.R., Wang J.K., Chen S., Iwase S., Alpatov R., Issaeva I., Canaani E., Roberts T.M., Chang H.Y., et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449 (2007) 689-694
137. Latres E., Malumbres M., Sotillo R., Martin J., Ortega S., Martin-Caballero J., Flores J.M., Cordon-Cardo C., and Barbacid M. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19 (2000) 3496-3506
138. Laumonnier F., Holbert S., Ronce N., Faravelli F., Lenzner S., Schwartz C.E., Lespinasse J., Van Esch H., Lacombe D., Goizet C., Phan-Dinh Tuy F., van Bokhoven H., et al. Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J. Med. Genet. 42 (2005) 780-786
139. Lee D.Y., Teyssier C., Strahl B.D., and Stallcup M.R. Role of protein methylation in regulation of transcription. Endocr. Rev. 26 (2005) 147-170
140. Lee M.G., Wynder C., Cooch N., and Shiekhattar R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437 (2005) 432-435
141. Lee M.G., Wynder C., Schmidt D.M., McCafferty D.G., and Shiekhattar R. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem. Biol. 13 (2006) 563-567
142. Lee J.S., Shukla A., Schneider J., Swanson S.K., Washburn M.P., Florens L., Bhaumik S.R., and Shilatifard A. Histone Crosstalk between H2B Monoubiquitination and H3 Methylation Mediated by COMPASS. Cell 131 (2007) 1084-1096
143. Lee J., Thompson J.R., Botuyan M.V., and Mer G. Distinct binding modes specify the recognition of methylated histones H3K4 and H4K20 by JMJD2A-tudor. Nat. Struct. Mol. Biol. 15 (2008) 109-111
144. Li Z., Cao R., Wang M., Myers M.P., Zhang Y., and Xu R.M. Structure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complex. J. Biol. Chem. 281 (2006) 20643-20649
145. Linnoila R.I., Zhao B., DeMayo J.L., Nelkin B.D., Baylin S.B., DeMayo F.J., and Ball D.W. Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice. Cancer Res. 60 (2000) 4005-4009
146. Loh Y.H., Zhang W., Chen X., George J., and Ng H.H. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21 (2007) 2545-2557
147. Lopez-Bigas N., Kisiel T.A., Dewaal D.C., Holmes K.B., Volkert T.L., Gupta S., Love J., Murray H.L., Young R.A., and Benevolenskaya E.V. Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol. Cell 31 (2008) 520-530
148. Lu P.J., Sundquist K., Baeckstrom D., Poulsom R., Hanby A., Meier-Ewert S., Jones T., Mitchell M., Pitha-Rowe P., Freemont P., and Taylor-Papadimitriou J. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J. Biol. Chem. 274 (1999) 15633-15645
149. Lubitz S., Glaser S., Schaft J., Stewart A.F., and Anastassiadis K. Increased apoptosis and skewed differentiation in mouse embryonic stem cells lacking the histone methyltransferase Mll2. Mol. Biol. Cell 18 (2007) 2356-2366
150. Luger K., Mader A.W., Richmond R.K., Sargent D.F., and Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389 (1997) 251-260
151. Majumder S., Liu Y., Ford III O.H., Mohler J.L., and Whang Y.E. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability. Prostate 66 (2006) 1292-1301
152. Margueron R., Li G., Sarma K., Blais A., Zavadil J., Woodcock C.L., Dynlacht B.D., and Reinberg D. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell 32 (2008) 503-518
153. Matthews A.G., Kuo A.J., Ramon-Maiques S., Han S., Champagne K.S., Ivanov D., Gallardo M., Carney D., Cheung P., Ciccone D.N., Walter K.L., Utz P.J., et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 450 (2007) 1106-1110
154. Metzger E., Wissmann M., Yin N., Muller J.M., Schneider R., Peters A.H., Gunther T., Buettner R., and Schule R. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437 (2005) 436-439
155. Metzger E., Yin N., Wissmann M., Kunowska N., Fischer K., Friedrichs N., Patnaik D., Higgins J.M., Potier N., Scheidtmann K.H., Buettner R., and Schule R. Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat. Cell Biol. 10 (2008) 53-60
156. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., Alvarez P., Brockman W., Kim T.K., Koche R.P., Lee W., Mendenhall E., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007) 553-560
157. Minucci S., and Pelicci P.G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6 (2006) 38-51
158. Mohd-Sarip A., Cleard F., Mishra R.K., Karch F., and Verrijzer C.P. Synergistic recognition of an epigenetic DNA element by Pleiohomeotic and a Polycomb core complex. Genes Dev. 19 (2005) 1755-1760
159. Mohd-Sarip A., van der Knaap J.A., Wyman C., Kanaar R., Schedl P., and Verrijzer C.P. Architecture of a polycomb nucleoprotein complex. Mol. Cell 24 (2006) 91-100
160. Mohd-Sarip A., Venturini F., Chalkley G.E., and Verrijzer C.P. Pleiohomeotic can link polycomb to DNA and mediate transcriptional repression. Mol. Cell. Biol. 22 (2002) 7473-7483
161. Mulligan P., Westbrook T.F., Ottinger M., Pavlova N., Chang B., Macia E., Shi Y.J., Barretina J., Liu J., Howley P.M., Elledge S.J., and Shi Y. CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol. Cell 32 (2008) 718-726
162. Nekrasov M., Klymenko T., Fraterman S., Papp B., Oktaba K., Kocher T., Cohen A., Stunnenberg H.G., Wilm M., and Muller J. Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes. EMBO J. 26 (2007) 4078-4088
163. Nelson C.J., Santos-Rosa H., and Kouzarides T. Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell 126 (2006) 905-916
164. Ng H.H., Feng Q., Wang H., Erdjument-Bromage H., Tempst P., Zhang Y., and Struhl K. Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev. 16 (2002) 1518-1527
165. Ng S.S., Kavanagh K.L., McDonough M.A., Butler D., Pilka E.S., Lienard B.M., Bray J.E., Savitsky P., Gileadi O., von Delft F., Rose N.R., Offer J., et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448 (2007) 87-91
166. Nishioka K., Rice J.C., Sarma K., Erdjument-Bromage H., Werner J., Wang Y., Chuikov S., Valenzuela P., Tempst P., Steward R., Lis J.T., Allis C.D., et al. PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol. Cell 9 (2002) 1201-1213
167. Okada Y., Feng Q., Lin Y., Jiang Q., Li Y., Coffield V.M., Su L., Xu G., and Zhang Y. hDOT1L links histone methylation to leukemogenesis. Cell 121 (2005) 167-178
168. Okada Y., Scott G., Ray M.K., Mishina Y., and Zhang Y. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature 450 (2007) 119-123
169. Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.P., Allis C.D., Cheng X., and Bestor T.H. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448 (2007) 714-717
170. Ozer A., and Bruick R.K. Non-heme dioxygenases: Cellular sensors and regulators jelly rolled into one?. Nat. Chem. Biol. 3 (2007) 144-153
171. Paik W.K., and Kim S. Enzymatic demethylation of calf thymus histones. Biochem. Biophys. Res. Commun. 51 (1973) 781-788
172. Paik W.K., and Kim S. Epsilon-alkyllysinase. New assay method, purification, and biological significance. Arch. Biochem. Biophys. 165 (1974) 369-378
173. Pal S., Baiocchi R.A., Byrd J.C., Grever M.R., Jacob S.T., and Sif S. Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. EMBO J. 26 (2007) 3558-3569
174. Pan G., Tian S., Nie J., Yang C., Ruotti V., Wei H., Jonsdottir G.A., Stewart R., and Thomson J.A. Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell. Stem Cell 1 (2007) 299-312
175. Pasini D., Hansen K.H., Christensen J., Agger K., Cloos P.A., and Helin K. Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2. Genes Dev. 22 (2008) 1345-1355
176. Perillo B., Ombra M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., Chiariotti L., Malorni A., Abbondanza C., and Avvedimento E.V. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319 (2008) 202-206
177. Pfau R., Tzatsos A., Kampranis S.C., Serebrennikova O.B., Bear S.E., and Tsichlis P.N. Members of a family of JmjC domain-containing oncoproteins immortalize embryonic fibroblasts via a JmjC domain-dependent process. Proc. Natl. Acad. Sci. USA 105 (2008) 1907-1912
178. Piao G.H., Piao W.H., He Y., Zhang H.H., Wang G.Q., and Piao Z. Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma. Histol. Histopathol. 23 (2008) 1171-1175
179. Pietersen A.M., and van Lohuizen M. Stem cell regulation by polycomb repressors: Postponing commitment. Curr. Opin. Cell Biol. 20 (2008) 201-207
180. Pollard P.J., Loenarz C., Mole D.R., McDonough M.A., Gleadle J.M., Schofield C.J., and Ratcliffe P.J. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem. J. 416 (2008) 387-394
181. Polytarchou C., Pfau R., Hatziapostolou M., and Tsichlis P.N. The JmjC domain histone demethylase Ndy1 regulates redox homeostasis and protects cells from oxidative stress. Mol. Cell. Biol. 28 (2008) 7451-7464
182. Pothof J., van Haaften G., Thijssen K., Kamath R.S., Fraser A.G., Ahringer J., Plasterk R.H., and Tijsterman M. Identification of genes that protect the C. elegans genome against mutations by genome-wide RNAi. Genes Dev. 17 (2003) 443-448
183. Qian C., Zhang Q., Li S., Zeng L., Walsh M.J., and Zhou M.M. Structure and chromosomal DNA binding of the SWIRM domain. Nat. Struct. Mol. Biol. 12 (2005) 1078-1085
184. Qiao Y., Liu X., Harvard C., Hildebrand M.J., Rajcan-Separovic E., Holden J.J., and Lewis M.E. Autism-associated familial microdeletion of Xp11.22. Clin. Genet. 74 (2008) 134-144
185. Raman J.D., Mongan N.P., Tickoo S.K., Boorjian S.A., Scherr D.S., and Gudas L.J. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin. Cancer Res. 11 (2005) 8570-8576
186. Rosati R., La Starza R., Veronese A., Aventin A., Schwienbacher C., Vallespi T., Negrini M., Martelli M.F., and Mecucci C. NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 99 (2002) 3857-3860
187. Rowley J.D. Rearrangements involving chromosome band 11Q23 in acute leukaemia. Semin. Cancer Biol. 4 (1993) 377-385
188. Rozovskaia T., Tillib S., Smith S., Sedkov Y., Rozenblatt-Rosen O., Petruk S., Yano T., Nakamura T., Ben-Simchon L., Gildea J., Croce C.M., Shearn A., et al. Trithorax and ASH1 interact directly and associate with the trithorax group-responsive bxd region of the Ultrabithorax promoter. Mol. Cell. Biol. 19 (1999) 6441-6447
189. Sanchez C., Sanchez I., Demmers J.A., Rodriguez P., Strouboulis J., and Vidal M. Proteomics analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor. Mol. Cell Proteomics 6 (2007) 820-834
190. Santi D.V., Garrett C.E., and Barr P.J. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 33 (1983) 9-10
191. Santos C., Rodriguez-Revenga L., Madrigal I., Badenas C., Pineda M., and Mila M. A novel mutation in JARID1C gene associated with mental retardation. Eur. J. Hum. Genet. 14 (2006) 583-586
192. Saramaki O.R., Tammela T.L., Martikainen P.M., Vessella R.L., and Visakorpi T. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer. Genes Chromosomes Cancer 45 (2006) 639-645
193. Sarma K., Margueron R., Ivanov A., Pirrotta V., and Reinberg D. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Mol. Cell. Biol. 28 (2008) 2718-2731
194. Schmidt D.M., and McCafferty D.G. Trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1. Biochemistry 46 (2007) 4408-4416
195. Schotta G., Lachner M., Sarma K., Ebert A., Sengupta R., Reuter G., Reinberg D., and Jenuwein T. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 18 (2004) 1251-1262
196. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., and Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 128 (2007) 735-745
197. Schurter B.T., Koh S.S., Chen D., Bunick G.J., Harp J.M., Hanson B.L., Henschen-Edman A., Mackay D.R., Stallcup M.R., and Aswad D.W. Methylation of histone H3 by coactivator-associated arginine methyltransferase 1. Biochemistry 40 (2001) 5747-5756
198. Schwartz Y.B., and Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat. Rev. Genet. 8 (2007) 9-22
199. Scibetta A.G., Santangelo S., Coleman J., Hall D., Chaplin T., Copier J., Catchpole S., Burchell J., and Taylor-Papadimitriou J. Functional analysis of the transcription repressor PLU-1/JARID1B. Mol. Cell. Biol. 27 (2007) 7220-7235
200. Scoumanne A., and Chen X. The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J. Biol. Chem. 282 (2007) 15471-15475
201. Scoumanne A., and Chen X. Protein methylation: A new mechanism of p53 tumor suppressor regulation. Histol. Histopathol. 23 (2008) 1143-1149
202. Secombe J., and Eisenman R.N. The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: The Myc connection. Cell Cycle 6 (2007) 1324-1328
203. Sellers W.R., and Loda M. The EZH2 polycomb transcriptional repressor-A marker or mover of metastatic prostate cancer?. Cancer Cell 2 (2002) 349-350
204. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., Wu E.A., Horner J.W., and DePinho R.A. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413 (2001) 86-91
205. Shi Y., and Whetstine J.R. Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25 (2007) 1-14
206. Shi Y., Sawada J., Sui G., Affarel B., Whetstine J.R., Lan F., Ogawa H., Luke M.P., Nakatani Y., and Shi Y. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422 (2003) 735-738
207. Shi Y., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A., Casero R.A., and Shi Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119 (2004) 941-953
208. Shi Y.J., Matson C., Lan F., Iwase S., Baba T., and Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol. Cell 19 (2005) 857-864
209. Shi X., Hong T., Walter K.L., Ewalt M., Michishita E., Hung T., Carney D., Pena P., Lan F., Kaadige M.R., Lacoste N., Cayrou C., et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442 (2006) 96-99
210. Shilatifard A. Chromatin modifications by methylation and ubiquitination: Implications in the regulation of gene expression. Annu. Rev. Biochem. 75 (2006) 243-269
211. Shin S., and Janknecht R. Diversity within the JMJD2 histone demethylase family. Biochem. Biophys. Res. Commun. 353 (2007) 973-977
212. Shirato H., Ogawa S., Nakajima K., Inagawa M., Kojima M., Tachibana M., Shinkai Y., and Takeuchi T. A Jumonji (Jarid2) protein complex represses cyclin D1 expression by methylation of histone H3-K9. J. Biol. Chem. 284 (2009) 733-739
213. Simon J.A., and Lange C.A. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat. Res. 647 (2008) 21-29
214. Sims III R.J., Millhouse S., Chen C.F., Lewis B.A., Erdjument-Bromage H., Tempst P., Manley J.L., and Reinberg D. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 28 (2007) 665-676
215. Singer M.S., Kahana A., Wolf A.J., Meisinger L.L., Peterson S.E., Goggin C., Mahowald M., and Gottschling D.E. Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics 150 (1998) 613-632
216. Sinha S.M., Singh R.D., Alam N.D., Roy A.D., Roychoudhury S.D., and Panda C.D. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma. Mol. Cancer 7 (2008) 84
217. Smothers J.F., and Henikoff S. The hinge and chromo shadow domain impart distinct targeting of HP1-like proteins. Mol. Cell. Biol. 21 (2001) 2555-2569
218. Sparmann A., and van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat. Rev. Cancer 6 (2006) 846-856
219. Spivakov M., and Fisher A.G. Epigenetic signatures of stem-cell identity. Nat. Rev. Genet. 8 (2007) 263-271
220. Stallcup M.R., Chen D., Koh S.S., Ma H., Lee Y.H., Li H., Schurter B.T., and Aswad D.W. Co-operation between protein-acetylating and protein-methylating co-activators in transcriptional activation. Biochem. Soc. Trans. 28 (2000) 415-418
221. Stavropoulos P., Blobel G., and Hoelz A. Crystal structure and mechanism of human lysine-specific demethylase-1. Nat. Struct. Mol. Biol. 13 (2006) 626-632
222. Steele-Perkins G., Fang W., Yang X.H., Van Gele M., Carling T., Gu J., Buyse I.M., Fletcher J.A., Liu J., Bronson R., Chadwick R.B., de la Chapelle A., et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 15 (2001) 2250-2262
223. Steger D.J., Lefterova M.I., Ying L., Stonestrom A.J., Schupp M., Zhuo D., Vakoc A.L., Kim J.E., Chen J., Lazar M.A., Blobel G.A., and Vakoc C.R. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol. Cell. Biol. 28 (2008) 2825-2839
224. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
225. Strahl B.D., Briggs S.D., Brame C.J., Caldwell J.A., Koh S.S., Ma H., Cook R.G., Shabanowitz J., Hunt D.F., Stallcup M.R., and Allis C.D. Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1. Curr. Biol. 11 (2001) 996-1000
226. Subramanian K., Jia D., Kapoor-Vazirani P., Powell D.R., Collins R.E., Sharma D., Peng J., Cheng X., and Vertino P.M. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol. Cell 30 (2008) 336-347
227. Surani M.A., Hayashi K., and Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 128 (2007) 747-762
228. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., Jenkins N.A., and Copeland N.G. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32 (2002) 166-174
229. Suzuki T., Minehata K., Akagi K., Jenkins N.A., and Copeland N.G. Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice. EMBO J. 25 (2006) 3422-3431
230. Suzuki C., Takahashi K., Hayama S., Ishikawa N., Kato T., Ito T., Tsuchiya E., Nakamura Y., and Daigo Y. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer. Mol. Cancer Ther. 6 (2007) 542-551
231. Tachibana M., Sugimoto K., Nozaki M., Ueda J., Ohta T., Ohki M., Fukuda M., Takeda N., Niida H., Kato H., and Shinkai Y. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16 (2002) 1779-1791
232. Tahiliani M., Mei P., Fang R., Leonor T., Rutenberg M., Shimizu F., Li J., Rao A., and Shi Y. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447 (2007) 601-605
233. Tan K., Shaw A.L., Madsen B., Jensen K., Taylor-Papadimitriou J., and Freemont P.S. Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9. J. Biol. Chem. 278 (2003) 20507-20513
234. Tatton-Brown K., Douglas J., Coleman K., Baujat G., Cole T.R., Das S., Horn D., Hughes H.E., Temple I.K., Faravelli F., Waggoner D., Turkmen S., et al. Genotype-phenotype associations in Sotos syndrome: An analysis of 266 individuals with NSD1 aberrations. Am. J. Hum. Genet. 77 (2005) 193-204
235. Taverna S.D., Li H., Ruthenburg A.J., Allis C.D., and Patel D.J. How chromatin-binding modules interpret histone modifications: Lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14 (2007) 1025-1040
236. Tenney K., and Shilatifard A. A COMPASS in the voyage of defining the role of trithorax/MLL-containing complexes: Linking leukemogensis to covalent modifications of chromatin. J. Cell. Biochem. 95 (2005) 429-436
237. Teye K., Tsuneoka M., Arima N., Koda Y., Nakamura Y., Ueta Y., Shirouzu K., and Kimura H. Increased expression of a Myc target gene Mina53 in human colon cancer. Am. J. Pathol. 164 (2004) 205-216
238. Teye K., Arima N., Nakamura Y., Sakamoto K., Sueoka E., Kimura H., and Tsuneoka M. Expression of Myc target gene mina53 in subtypes of human lymphoma. Oncol. Rep. 18 (2007) 841-848
239. Tong J.K., Hassig C.A., Schnitzler G.R., Kingston R.E., and Schreiber S.L. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395 (1998) 917-921
240. Torres-Padilla M.E., Parfitt D.E., Kouzarides T., and Zernicka-Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature 445 (2007) 214-218
241. Tremethick D.J. Higher-order structures of chromatin: The elusive 30 nm fiber. Cell 128 (2007) 651-654
242. Trewick S.C., Henshaw T.F., Hausinger R.P., Lindahl T., and Sedgwick B. Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage. Nature 419 (2002) 174-178
243. Trewick S.C., McLaughlin P.J., and Allshire R.C. Methylation: Lost in hydroxylation?. EMBO Rep. 6 (2005) 315-320
244. Trojer P., and Reinberg D. Histone lysine demethylases and their impact on epigenetics. Cell 125 (2006) 213-217
245. Trojer P., Zhang J., Yonezawa M., Schmidt A., Zheng H., Jenuwein T., and Reinberg D. Dynamic histone H1 isotype 4 methylation and demethylation by histone lysine methyltransferase G9a/KMT1C and the jumonji domain-containing JMJD2/KDM4 proteins. J. Biol. Chem. 284 (2009) 8395-8405
246. Tsai W.W., Nguyen T.T., Shi Y., and Barton M.C. p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivo. Mol. Cell. Biol. 28 (2008) 5139-5146
247. Tsichlis P.N., and Lazo P.A. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr. Top. Microbiol. Immunol. 171 (1991) 95-171
248. Tsukada Y., Fang J., Erdjument-Bromage H., Warren M.E., Borchers C.H., Tempst P., and Zhang Y. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439 (2006) 811-816
249. Tsuneoka M., Koda Y., Soejima M., Teye K., and Kimura H. A novel myc target gene, mina53, that is involved in cell proliferation. J. Biol. Chem. 277 (2002) 35450-35459
250. Tsuneoka M., Fujita H., Arima N., Teye K., Okamura T., Inutsuka H., Koda Y., Shirouzu K., and Kimura H. Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. Clin. Cancer Res. 10 (2004) 7347-7356
251. Tu S., Teng Y.C., Yuan C., Wu Y.T., Chan M.Y., Cheng A.N., Lin P.H., Juan L.J., and Tsai M.D. The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif. Nat. Struct. Mol. Biol. 15 (2008) 419-421
252. Tzatsos A., Pfau R., Kampranis S.C., and Tsichlis P.N. Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus. Proc. Natl. Acad. Sci. USA 106 (2009) 2641-2646
253. Tzschach A., Lenzner S., Moser B., Reinhardt R., Chelly J., Fryns J.P., Kleefstra T., Raynaud M., Turner G., Ropers H.H., Kuss A., and Jensen L.R. Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. Hum. Mutat. 27 (2006) 389
254. Uren A.G., Kool J., Matentzoglu K., de Ridder J., Mattison J., van Uitert M., Lagcher W., Sie D., Tanger E., Cox T., Reinders M., Hubbard T.J., et al. Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell 133 (2008) 727-741
255. Vakoc C.R., Mandat S.A., Olenchock B.A., and Blobel G.A. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol. Cell 19 (2005) 381-391
256. van Leeuwen F., Gafken P.R., and Gottschling D.E. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109 (2002) 745-756
257. van Oevelen C., Wang J., Asp P., Yan Q., Kaelin Jr. W.G., Kluger Y., and Dynlacht B.D. A role for mammalian Sin3 in permanent gene silencing. Mol. Cell 32 (2008) 359-370
258. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., and Chinnaiyan A.M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419 (2002) 624-629
259. Varambally S., Cao Q., Mani R.S., Shankar S., Wang X., Ateeq B., Laxman B., Cao X., Jing X., Ramnarayanan K., Brenner J.C., Yu J., et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322 (2008) 1695-1699
260. Vermeulen M., Mulder K.W., Denissov S., Pijnappel W.W., van Schaik F.M., Varier R.A., Baltissen M.P., Stunnenberg H.G., Mann M., and Timmers H.T. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 131 (2007) 58-69
261. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., Van Eynde A., Bernard D., Vanderwinden J.M., Bollen M., Esteller M., et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439 (2006) 871-874
262. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., and Zhang Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293 (2001) 853-857
263. Wang H., Wang L., Erdjument-Bromage H., Vidal M., Tempst P., Jones R.S., and Zhang Y. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431 (2004) 873-878
264. Wang Y., Wysocka J., Sayegh J., Lee Y.H., Perlin J.R., Leonelli L., Sonbuchner L.S., McDonald C.H., Cook R.G., Dou Y., Roeder R.G., Clarke S., et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306 (2004) 279-283
265. Wang G.G., Cai L., Pasillas M.P., and Kamps M.P. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat. Cell Biol. 9 (2007) 804-812
266. Wang L., Pal S., and Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol. Cell. Biol. 28 (2008) 6262-6277
267. Wang S.C., Oelze B., and Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 3 (2008) e2698
268. Wang J., Hevi S., Kurash J.K., Lei H., Gay F., Bajko J., Su H., Sun W., Chang H., Xu G., Gaudet F., Li E., et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet. 41 (2009) 125-129
269. Wellmann S., Bettkober M., Zelmer A., Seeger K., Faigle M., Eltzschig H.K., and Buhrer C. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem. Biophys. Res. Commun. 372 (2008) 892-897
270. Whetstine J.R., Nottke A., Lan F., Huarte M., Smolikov S., Chen Z., Spooner E., Li E., Zhang G., Colaiacovo M., and Shi Y. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125 (2006) 467-481
271. Wilsker D., Patsialou A., Dallas P.B., and Moran E. ARID proteins: A diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ. 13 (2002) 95-106
272. Wissmann M., Yin N., Muller J.M., Greschik H., Fodor B.D., Jenuwein T., Vogler C., Schneider R., Gunther T., Buettner R., Metzger E., and Schule R. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol. 9 (2007) 347-353
273. Wysocka J., Allis C.D., and Coonrod S. Histone arginine methylation and its dynamic regulation. Front. Biosci. 11 (2006) 344-355
274. Wysocka J., Swigut T., Xiao H., Milne T.A., Kwon S.Y., Landry J., Kauer M., Tackett A.J., Chait B.T., Badenhorst P., Wu C., and Allis C.D. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442 (2006) 86-90
275. Xiang Y., Zhu Z., Han G., Ye X., Xu B., Peng Z., Ma Y., Yu Y., Lin H., Chen A.P., and Chen C.D. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl. Acad. Sci. USA 104 (2007) 19226-19231
276. Xiao B., Jing C., Kelly G., Walker P.A., Muskett F.W., Frenkiel T.A., Martin S.R., Sarma K., Reinberg D., Gamblin S.J., and Wilson J.R. Specificity and mechanism of the histone methyltransferase Pr-Set7. Genes Dev. 19 (2005) 1444-1454
277. Yagi H., Deguchi K., Aono A., Tani Y., Kishimoto T., and Komori T. Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. Blood 92 (1998) 108-117
278. Yamagishi T., Hirose S., and Kondo T. Secondary DNA structure formation for Hoxb9 promoter and identification of its specific binding protein. Nucleic Acids Res. 36 (2008) 1965-1975
279. Yamane K., Toumazou C., Tsukada Y., Erdjument-Bromage H., Tempst P., Wong J., and Zhang Y. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125 (2006) 483-495
280. Yamane K., Tateishi K., Klose R.J., Fang J., Fabrizio L.A., Erdjument-Bromage H., Taylor-Papadimitriou J., Tempst P., and Zhang Y. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 25 (2007) 801-812
281. Yang Z.Q., Imoto I., Fukuda Y., Pimkhaokham A., Shimada Y., Imamura M., Sugano S., Nakamura Y., and Inazawa J. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer. Res. 60 (2000) 4735-4739
282. Yang Z.Q., Imoto I., Pimkhaokham A., Shimada Y., Sasaki K., Oka M., and Inazawa J. A novel amplicon at 9p23-24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB. Jpn J. Cancer Res. 92 (2001) 423-428
283. Yang M., Gocke C.B., Luo X., Borek D., Tomchick D.R., Machius M., Otwinowski Z., and Yu H. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol. Cell 23 (2006) 377-387
284. Yoon K.A., Park S., Hwangbo B., Shin H.D., Cheong H.S., Shin H.R., and Lee J.S. Genetic polymorphisms in the Rb-binding zinc finger gene RIZ and the risk of lung cancer. Carcinogenesis 28 (2007) 1971-1977
285. You A., Tong J.K., Grozinger C.M., and Schreiber S.L. CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc. Natl. Acad. Sci. USA 98 (2001) 1454-1458
286. Yu B.D., Hanson R.D., Hess J.L., Horning S.E., and Korsmeyer S.J. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis. Proc. Natl. Acad. Sci. USA 95 (1998) 10632-10636
287. Zeitlinger J., Stark A., Kellis M., Hong J.W., Nechaev S., Adelman K., Levine M., and Young R.A. RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo. Nat. Genet. 39 (2007) 1512-1516
288. Zhang Y., and Reinberg D. Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes Dev. 15 (2001) 2343-2360
289. Zhang Q., Hu C.M., Yuan Y.S., He C.H., Zhao Q., and Liu N.Z. Expression of Mina53 and its significance in gastric carcinoma. Int. J. Biol. Markers 23 (2008) 83-88
290. Zhao X.D., Han X., Chew J.L., Liu J., Chiu K.P., Choo A., Orlov Y.L., Sung W.K., Shahab A., Kuznetsov V.A., Bourque G., Oh S., et al. Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell. Stem Cell 1 (2007) 286-298
291. Zhu Q., Liu C., Ge Z., Fang X., Zhang X., Straat K., Bjorkholm M., and Xu D. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene. PLoS ONE 3 (2008) e1446
292. Zilberman D., Gehring M., Tran R.K., Ballinger T., and Henikoff S. Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription. Nat. Genet. 39 (2007) 61-69